Reuters logo
Celgene quarterly profit rises 17.5 percent
2017年4月27日 / 中午11点39分 / 7 个月前

Celgene quarterly profit rises 17.5 percent

April 27 (Reuters) - U.S. biotechnology company Celgene Corp reported a 17.5 percent jump in quarterly net income on Thursday, helped by demand for its flagship multiple myeloma drug Revlimid.

The company’s net income rose to $941 million, or $1.16 per share, in the first quarter ended March 31, from $801 million, or 99 cents per share, a year earlier.

Total revenue rose to $2.96 billion from $2.51 billion. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Shounak Dasgupta)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below